Prescribers | All Chapters 1-57 covered | 2025 update.
6th Edition
Teri Moser WooRN, PhD, ARNP, CPNP-PC, CNL, FAANP
Wendy L. WrightDNP, ANP-BC, FNP-BC, FAAN, FNAP
,Chapter 1: The Role of the Nurse Practitioner as Prescriber
1.
A 48-year-old patient presents to a primary care clinic for follow-up on hypertension. As a
nurse practitioner in a full-practice authority state, what is your responsibility in
prescribing?
A. Prescribe under the direct supervision of a physician
B. Prescribe medications only after consulting the collaborating physician
C. Independently assess, diagnose, and prescribe medications
D. Write prescriptions but require co-signature from a pharmacist
ANS: C
Rationale: In full-practice authority states, nurse practitioners can independently assess,
diagnose, and prescribe. This aligns with the APRN Consensus Model and AANP
guidelines.
2.
Which of the following is a key component of rational prescribing as outlined in the WHO
6-step model?
A. Prescribing based solely on patient preference
B. Selecting medications based on drug company incentives
C. Defining the patient’s problem and therapeutic objective before selecting treatment
D. Initiating treatment prior to establishing a diagnosis
ANS: C
Rationale: The WHO model emphasizes beginning with a clear definition of the clinical
problem and therapeutic goal. This framework ensures safe and rational prescribing.
3.
A nurse practitioner is prescribing a new antihypertensive medication. What must they
document to meet ethical and legal standards?
A. The brand name only
B. Only the dosage form
C. Clinical rationale, drug name, dosage, route, and frequency
D. Prescribing based on another provider’s recommendation
ANS: C
Rationale: Complete documentation ensures transparency and accountability. It
supports clinical reasoning and meets professional and legal requirements.
,4.
A 65-year-old female with type 2 diabetes expresses concern about a new medication’s
cost. What prescribing strategy supports patient-centered care and improves compliance?
A. Prescribe the brand-name drug for better efficacy
B. Offer samples for a short-term solution
C. Explore lower-cost alternatives and include the patient in the decision
D. Refer the patient to a social worker instead
ANS: C
Rationale: Engaging the patient in cost discussions and offering effective generics
supports adherence and reflects ethical, individualized care.
5.
In a reduced-practice authority state, which statement best describes the NP's
prescribing role?
A. NPs may only prescribe herbal therapies
B. NPs must work under direct physician supervision at all times
C. NPs must have a regulated collaborative agreement for certain prescribing activities
D. NPs may independently prescribe controlled substances
ANS: C
Rationale: In reduced-practice states, NPs require a collaborative agreement for specific
aspects of patient care, including prescribing. This varies by state legislation.
6.
A new NP is prescribing an opioid for acute pain management. What is the most
appropriate action to prevent misuse?
A. Prescribe the maximum allowable quantity
B. Skip the prescription and recommend NSAIDs
C. Check the state's prescription drug monitoring program (PDMP)
D. Delegate prescribing authority to a medical assistant
ANS: C
Rationale: Consulting the PDMP before prescribing controlled substances helps identify
potential misuse and is often required by law.
, 7.
Which federal act governs the classification of controlled substances that NPs may
prescribe?
A. Affordable Care Act
B. Drug Enforcement Administration (DEA) Act
C. Controlled Substances Act
D. Health Insurance Portability and Accountability Act (HIPAA)
ANS: C
Rationale: The Controlled Substances Act (CSA) sets the legal foundation for drug
scheduling and the prescribing authority for controlled substances.
8.
An NP prescribes a medication off-label. What must be included in the patient education
process?
A. Avoid discussing that it's off-label
B. State that the use is experimental
C. Inform the patient about the evidence supporting this use
D. Reassure the patient that FDA approval is irrelevant
ANS: C
Rationale: Off-label prescribing is legal when evidence supports the use. Ethical practice
requires full disclosure of rationale and risks.
9.
Which organization provides clinical practice guidelines that help nurse practitioners
make prescribing decisions based on current evidence?
A. American Medical Association
B. Centers for Medicare & Medicaid Services
C. American Association of Nurse Practitioners
D. U.S. Preventive Services Task Force (USPSTF)
ANS: D
Rationale: The USPSTF offers evidence-based recommendations on preventive services
and treatment strategies that inform safe prescribing.
10.
A nurse practitioner in a collaborative agreement practice state wants to prescribe a